Labeling of products currently under FDA review.

OSHA interpretation letter responding to INCSTAR Corporation's request that its in-vitro diagnostic kits be exempted from additional labeling under 29 CFR 1910.1030(g)(1)(i)(F). It states the company's FDA-reviewed labeling appears to meet the exemption's conditions, while other protections of the standard still apply.